CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 121 filers reported holding CARA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $300,000 | +29.3% | 19,400 | 0.0% | 0.00% | – |
Q2 2021 | $232,000 | -44.9% | 19,400 | 0.0% | 0.00% | – |
Q1 2021 | $421,000 | +43.2% | 19,400 | 0.0% | 0.00% | – |
Q4 2020 | $294,000 | +19.0% | 19,400 | 0.0% | 0.00% | – |
Q3 2020 | $247,000 | -25.6% | 19,400 | 0.0% | 0.00% | – |
Q2 2020 | $332,000 | +29.7% | 19,400 | 0.0% | 0.00% | – |
Q1 2020 | $256,000 | -18.2% | 19,400 | 0.0% | 0.00% | – |
Q4 2019 | $313,000 | -11.8% | 19,400 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $355,000 | -14.9% | 19,400 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $417,000 | +9.4% | 19,400 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $381,000 | +51.2% | 19,400 | 0.0% | 0.00% | – |
Q4 2018 | $252,000 | -45.8% | 19,400 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $465,000 | +25.0% | 19,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $372,000 | +56.3% | 19,400 | +1.0% | 0.00% | – |
Q1 2018 | $238,000 | +1.3% | 19,200 | 0.0% | 0.00% | – |
Q4 2017 | $235,000 | -12.3% | 19,200 | -2.0% | 0.00% | – |
Q3 2017 | $268,000 | +17.5% | 19,600 | +32.4% | 0.00% | – |
Q2 2017 | $228,000 | – | 14,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,568,057 | $70,005,000 | 74.08% |
Chescapmanager LLC | 1,203,055 | $23,604,000 | 2.80% |
Mesirow Financial Investment Management, Inc. | 29,821 | $585,000 | 2.32% |
DAFNA Capital Management LLC | 143,611 | $2,818,000 | 1.22% |
Opaleye Management Inc. | 200,000 | $3,924,000 | 1.09% |
SPHERA FUNDS MANAGEMENT LTD. | 303,930 | $5,963,000 | 0.54% |
DISCIPLINED GROWTH INVESTORS INC /MN | 852,892 | $16,734,000 | 0.29% |
DLD Asset Management, LP | 352,700 | $6,927,000 | 0.26% |
SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 54,984 | $1,079,000 | 0.18% |
B. Riley Wealth Management, Inc. | 33,755 | $662,000 | 0.12% |